Craig-Hallum Maintains Buy on MiMedx Group, Raises Price Target to $8
Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $6 to $8.
Read original at benzingaMarkets · News reference
Medicare Could Run Out of Money in 7 Years — Dr. Oz Says Trump Has a Plan to Make It Last Twice as Long
Mehmet Oz outlines fraud cuts, drug pricing and AI as key tools to extend Medicare solvency.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
No ticker was attached by the source feed.
- Source
- benzinga
- Observed
- Aug 24, 2026, 12:16 PM
- Checked
- Aug 24, 2026, 1:28 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Mizuho Maintains Outperform on Veeva Systems, Raises Price Target to $280
Mizuho analyst Steven Valiquette maintains Veeva Systems (NYSE:VEEV) with a Outperform and raises the price target from $270 to $280.
Read original at benzingaBitcoin Taps $80,000 as ETH, XRP Gain Between 3% and 6% Ahead of Jackson Hole
Bitcoin at $80,000, traders watching key levels for push higher or pullback. Spot ETFs continue to witness net inflows.
Read original at benzingaMizuho Maintains Neutral on Simon Property Group, Raises Price Target to $226
Mizuho analyst Vikram Malhorta maintains Simon Property Group (NYSE:SPG) with a Neutral and raises the price target from $211 to $226.
Read original at benzingaQUICK SPARK: Meta Paid Nearly $17 Billion — Now It's Changing How Teens Use Instagram
Meta's nearly $17 billion settlement is grabbing headlines, but the bigger story is how it's changing Instagram for teens.
Read original at benzingaMizuho Maintains Outperform on Synopsys, Lowers Price Target to $550
Mizuho analyst Siti Panigrahi maintains Synopsys (NASDAQ:SNPS) with a Outperform and lowers the price target from $600 to $550.
Read original at benzinga